@prymal

Eli Lilly dropped topline results for the TRIUMPH-1 Phase 3 trial yesterday, May 21, 2026. The numbers are hard to ignore. Retatrutide (LY3437943) is a triple hormone receptor agonist. It hits GLP-1, GIP, and glucagon receptors at the same time. That glucagon piece is what makes it different...

Hey crew, Just received my first bundle of goods from @Prymal - the dude has been super solid to deal with, fast to reply, answered all questions I had and just all round good human. Goods received packaged well as per pic with super neat branding & itemising on each packaged into hard shell...